| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 125,500 options to buy
@ $3.21, valued at
$402.9k
|
|
| 04/04/2022 |
4
| Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 7,068 shares
@ $4.88, valued at
$34.5k
Exercised 16,668 restricted stock units
@ $0 |
|
| 03/29/2022 |
4
| Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 82,000 options to buy
@ $6.91, valued at
$566.6k
Granted 21,333 options to buy
@ $5.01, valued at
$106.9k
|
|
| 11/17/2021 |
4
| Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 8,000 shares
@ $18.05, valued at
$144.4k
Exercised 8,000 options to buy
@ $8.26, valued at
$66.1k
|
|
| 11/15/2021 |
4
| Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 20,000 shares
@ $15.0677, valued at
$301.4k
Exercised 20,000 options to buy
@ $6.42, valued at
$128.4k
|
|
| 10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 800 shares
@ $20.01, valued at
$16k
Exercised 800 options to buy
@ $6.42, valued at
$5.1k
|
|
| 08/05/2020 |
4
| Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 5,800 shares
@ $20.01, valued at
$116.1k
Sold 400 shares
@ $20.14, valued at
$8.1k
Exercised 2,000 options to buy
@ $8.26, valued at
$16.5k
Exercised 3,800 options to buy
@ $6.42, valued at
$24.4k
Exercised 400 options to buy
@ $6.42, valued at
$2.6k
|
|
| 04/10/2020 |
4
| Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 5,354 shares
@ $0
Granted 50,000 restricted stock units
@ $0
Exercised 16,666 restricted stock units
@ $0 |
|
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2019 |
4
| Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $6.42, valued at
$963k
Granted 100,000 options to buy
@ $11.54, valued at
$1.2M
|
|
| 12/26/2018 |
4
| Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Bought 2,000 shares
@ $4.37, valued at
$8.7k
|
|
| 08/16/2018 |
4
| Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.26, valued at
$165.2k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |